Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Sunshine Biopharma Inc (NASDAQ: SBFM) closed at $2.97 in the last session, down -5.41% from day before closing price of $3.14. In other words, the price has decreased by -$5.41 from its previous closing price. On the day, 0.13 million shares were traded. SBFM stock price reached its highest trading level at $3.14 during the session, while it also had its lowest trading level at $2.95.
Ratios:
We take a closer look at SBFM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.57 and its Current Ratio is at 5.74. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Slilaty Steve N. bought 100,000 shares for $0.10 per share. The transaction valued at 10,000 led to the insider holds 130,000 shares of the business.
Slilaty Steve N. bought 20,000 shares of SBFM for $2,000 on Feb 08 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $0.10 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 5938990 and an Enterprise Value of -5698114. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 0.24. Its current Enterprise Value per Revenue stands at -0.173 whereas that against EBITDA is 1.197.
Stock Price History:
Over the past 52 weeks, SBFM has reached a high of $571.20, while it has fallen to a 52-week low of $2.11. The 50-Day Moving Average of the stock is 5.71%, while the 200-Day Moving Average is calculated to be -84.91%.
Shares Statistics:
According to the various share statistics, SBFM traded on average about 683.60K shares per day over the past 3-months and 194040 shares per day over the past 10 days. A total of 2.00M shares are outstanding, with a floating share count of 2.00M. Insiders hold about 0.10% of the company’s shares, while institutions hold 1.98% stake in the company. Shares short for SBFM as of 1734048000 were 474246 with a Short Ratio of 0.69, compared to 1731628800 on 234056. Therefore, it implies a Short% of Shares Outstanding of 474246 and a Short% of Float of 23.74.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $12.5M. It ranges from a high estimate of $12.5M to a low estimate of $12.5M. As of the current estimate, Sunshine Biopharma Inc’s year-ago sales were $7.68M
A total of 1 analysts have provided revenue estimates for SBFM’s current fiscal year. The highest revenue estimate was $27.78M, while the lowest revenue estimate was $27.78M, resulting in an average revenue estimate of $27.78M. In the same quarter a year ago, actual revenue was $24.09MBased on 1 analysts’ estimates, the company’s revenue will be $100M in the next fiscal year. The high estimate is $100M and the low estimate is $100M.
